3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Pancreatic Neoplasms
22
Triple Negative Breast Neoplasms
9
Lung Neoplasms
8
Neoplasm Metastasis
7
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms
4
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Resectable Pancreatic Cancer
1
Pancreatic Adenocarcinoma
1
Osteosarcoma
1
Neoplasms, Basal Cell
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Interventions
Temozolomide
10
Radiotherapy
5
Radiation
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
Specimen Handling
2
Photons
2
Nivolumab
2
veliparib
1
sargramostim
1
peposertib
1
montanide ISA 51
1
liposomal doxorubicin
1
cemiplimab
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Utrogestan
1
Surgical Procedures, Operative
1
Sonication
1
Progestins
1
Progesterone
1
Perfusion Magnetic Resonance Imaging
1
Mycophenolic Acid
1
Lomustine
1
Irinotecan
1
Drug Therapy
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gliosarcoma
×
Albumin-Bound Paclitaxel
×
90 days
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled